Clinical Trial Update: Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating contrast-enhanced whole-heart coronary MRA at 3.0T has completed. The study investigates imaging performance for coronary artery diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Coronary Artery Disease | Phase 1 | Status: COMPLETED